Affiliations 

  • 1 Allergy and Immunology, University of the Philippines - Philippine General Hospital, Manila, Philippines
  • 2 Gleneagles Hospital, Kuala Lumpur, Malaysia
  • 3 Department of Dermatology & Whole-Genome Research Core, Laboratory of Human Diseases, Taipei, Taiwan
  • 4 Department of Paediatrics and Adolescent Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong SAR, China
  • 5 D.Y.Patil University and School of Medicine, Navi Mumbai, India
  • 6 Department of Dermatology, Research Institute for Tropical Medicine, Muntinlupa, Philippines
  • 7 Department of Clinical Immunology and Allergy, Concord Repatriation General Hospital, Sydney, Australia
  • 8 Sunway Medical Centre Velocity, Kuala Lumpur, Malaysia
  • 9 Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
  • 10 Division of Allergy & Clinical Immunology, Department of Paediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
  • 11 Department of Dermatology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China
  • 12 Clinical Research Center, Bệnh viện Da liễu Trung ương, Hanoi, Viet Nam
  • 13 Department of Pediatrics, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
  • 14 Menarini Asia-Pacific Holdings Pte Ltd, Singapore
World Allergy Organ J, 2024 Nov;17(11):100984.
PMID: 39553289 DOI: 10.1016/j.waojou.2024.100984

Abstract

BACKGROUND: Chronic urticaria (CU), in both inducible and spontaneous forms, is associated with a substantial burden in the Asia-Pacific region (APAC). Patient-centred care recognises patients desire to be involved in decisions regarding their health. Although patient-centred approaches have previously not been studied in the context of CU management, they have demonstrated benefits in the management of other chronic conditions.

METHODS: Information and opinions regarding the barriers and solutions to the implementation of patient-centred approaches to the management of CU were gathered from a group of 13 expert dermatologists and allergist/immunologists from APAC through surveys and a face-to-face meeting.

RESULTS: Barriers identified there included a lack of awareness of CU amongst patients, delays in consulting healthcare providers, financial constraints, and low adherence. Particular issues raised included a lack of suitable online information for patients (83% of experts), and patients accessing oral corticosteroids without a prescription. Compliance issues were also identified as key reasons for inadequate responses to treatments (67% of experts). Solutions proposed by the authors were improving patients' knowledge about their condition (92% strongly agree, 8% agree), physicians' consideration of patient characteristics when choosing treatments (92% strongly agree, 8% agree), implementing shared decision-making (85% strongly agree, 15% agree), and using patient-reported outcome measures (70% strongly agree, 23% agree).

CONCLUSION: Expert opinion within APAC supports the use of patient-centred approaches to improve the management of CU. We provide several recommendations focusing on patient education and involvement in disease management as well as disease monitoring methods that can be implemented by physicians in APAC.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.